Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-03
1996-10-08
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546156, A61K 3147, C07D21556
Patent
active
055631550
ABSTRACT:
Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones are described, their therapeutic advantages as antibacterial agents, as well as a novel method for the preparation and isolation of such stereoisomers.
REFERENCES:
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4780468 (1988-10-01), Bridges et al.
patent: 4997943 (1991-03-01), Iwata et al.
patent: 5043450 (1991-08-01), Masuzawa et al.
patent: 5098912 (1992-03-01), Hayakawa et al.
Kimura et al., Published Abstract from International Congress of Antimicrobial Agents and Chemotherapy (ICAAC), Paper No. 1192, Houston, Texas (1989).
DeCamp, Chirality, vol. 1, pp. 2-6 (1989).
Cayen, Chirality, vol. 3, pp. 94-98 (1991).
Domagala John M.
Kiely John S.
Schroeder Mel C.
Ashbrook Charles W.
Dentz Bernard
Warner-Lambert & Company
LandOfFree
Individual stereosiomers of 7-[3-(aminoalkyl)-1-pyrrolidinyl]-qu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Individual stereosiomers of 7-[3-(aminoalkyl)-1-pyrrolidinyl]-qu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Individual stereosiomers of 7-[3-(aminoalkyl)-1-pyrrolidinyl]-qu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-57584